The current FDA status of BPC-157 is that of an unapproved drug compound with no active Investigational New Drug (IND) application accepted for human clinical trials as of available records
Liu L, Zhao C, Heng HH, Ganz T: The human -defensin-1 and -defensins are encoded by adjacent genes: Two peptide families with differing disulfide topology share a common ancestry
Because there is not enough high-quality human evidence to support routine clinical use and they are not currently approved for use in Humans by Health Canada or the FDA
During the lyophilization (freeze-drying) process, the peptide often forms a solid, compacted puck or disc at the bottom of the vial
And what they found was that as migraine headaches went up, sodium levels were down
Their are several proposed benefits of these changes which include the following: Cognitive clarity Neuroprotection Reduced risk of neurodegeneration How 5-Amino-1MQ Helps Women Feel Stronger and Healthier